Clinical Trial

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated April 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, single arm, single-center clinical study to test NVDX3 in patients suffering from low grade one level degenerative lumbar (L1 - S1) spondylolisthesis. NVDX3 will be implanted during a single surgical intervention.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-07-18; most recent amendment 2025-12-18.
Status change: Recruiting → Active, Not Recruiting 2024-07-29
Status change: Not Yet Recruiting → Recruiting 2023-11-21
Trial Details
NCT Number NCT05961956
Lead Sponsor Novadip Biosciences
Conditions Degenerative Lumbar Spondylolisthesis
Enrollment 5 participants
Start Date 2023-10-12
Primary Completion 2026-04-18 (estimated)
Study Completion 2026-04-18 (estimated)
Updated on ClinicalTrials.gov 2025-12-24